Invasive deep-brain stimulation is increasingly being investigated as a treatment for neural disorders. A non-invasive alternative for deep-brain neuromodulation would likely broaden the range of application. However, existing techniques, such as transcranial electrical or magnetic stimulation (TES, TMS), are limited in their depth of stimulation. In this work, we propose DeepFocus, a new minimally invasive approach for stimulation of the deep brain by inserting electrodes in nasal cavities in conjunction with conventional scalp electrodes. As an initial step, an ex vivo model was designed to quantify the current efficiency of the proposed electrode placement in eliciting neural responses. A simplified geometric configuration was employed, where two linear electrode arrays arranged perpendicularly were used to elicit local field potentials (LFP) in mouse brain slices. Through a combination of finite element simulations to model the electric fields, and LFP measurements, we observed that electrode-patterns that use both arrays (modeling transnasal and scalp electrodes) generated higher electric fields and required less current to evoke responses compared to those that use only a single array (modeling scalp-only or transnasal-only). The benefits of two-array stimulation increased as the distance between the electrodes and the brain slice was increased. In addition, we observed that the relative orientation of the electric field compared to the cortical columns affected the neural responses.

Download full-text PDF

Source
http://dx.doi.org/10.1109/EMBC53108.2024.10781751DOI Listing

Publication Analysis

Top Keywords

deep-brain stimulation
8
scalp electrodes
8
neural responses
8
electric fields
8
stimulation
6
vivo studies
4
studies efficacy
4
efficacy deepfocus
4
deepfocus technique
4
technique minimally-invasive
4

Similar Publications

Parkinson's disease is characterized, in part, by hypoactivity of direct pathway inhibitory projections from striatum to the globus pallidus internus (GPi) and indirect pathway inhibitory projections from globus pallidus externus (GPe) to the subthalamic nucleus (STN). In people with Parkinson's disease (n=32), we explored the potential use of intracranial stimulation for eliciting long-term potentiation (LTP) of these underactive pathways to produce improvement of symptoms that persists beyond stimulation cessation. During GPi deep brain stimulation (DBS) surgery, we found strong evidence (p<.

View Article and Find Full Text PDF

Could adaptive deep brain stimulation treat freezing of gait in Parkinson's disease?

J Neurol

March 2025

Centre for Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research, University of Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Germany.

Next-generation neurostimulators capable of running closed-loop adaptive deep brain stimulation (aDBS) are about to enter the clinical landscape for the treatment of Parkinson's disease. Already promising results using aDBS have been achieved for symptoms such as bradykinesia, rigidity and motor fluctuations. However, the heterogeneity of freezing of gait (FoG) with its wide range of clinical presentations and its exacerbation with cognitive and emotional load make it more difficult to predict and treat.

View Article and Find Full Text PDF

Depression is a common comorbidity in Parkinson's disease (PD), significantly reducing patients' quality of life. This mini-review examines pharmacological and nonpharmacological therapies for managing depression in PD, analyzing their benefits, and limitations. Pharmacological options include tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), levodopa, dopaminergic agonists, and monoamine oxidase B inhibitors.

View Article and Find Full Text PDF

The Deep Brain Stimulation (DBS) Think Tank XII was held on August 21st to 23rd. This year we showcased groundbreaking advancements in neuromodulation technology, focusing heavily on the novel uses of existing technology as well as next-generation technology. Our keynote speaker shared the vision of using neuro artificial intelligence to predict depression using brain electrophysiology.

View Article and Find Full Text PDF

Motor symptoms are central to diagnosing Parkinson's disease (PD), but depression and anxiety significantly impact the prognosis and course of PD. For many PD patients, these mental health issues may be the most crucial determinants of quality of life. This study uses an interdisciplinary approach to provide an in-depth understanding of the pathogenesis, diagnostic methods, and therapeutic strategies for depression and anxiety in PD, incorporating neuroscience, psychiatry, and psychology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!